December 15, 2023
Federal prosecutors urged a Pennsylvania federal judge on Friday to reject Teva Pharmaceuticals' attempt to unseal a letter explaining the government's decision to drop generic drug price-fixing charges against a New York pharmaceutical marketing executive, saying the letter isn't subject to the First Amendment's right of access.
November 17, 2023
A New York pharmaceutical marketing executive will have his Pennsylvania federal court case dropped after prosecutors on Thursday asked to dismiss the three charges alleging he participated in a scheme to fix prices of generic drugs.
March 28, 2023
The U.S. Department of Justice has pushed back against a bid by a former pharmaceutical executive accused of taking part in conspiracies to fix generic drug prices to delay a pending October trial, arguing that the case has already been pending for three years.
November 09, 2022
A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
January 03, 2021
U.S. technology companies are facing a mountain of antitrust litigation heading into 2021, as enforcers push blockbuster monopolization cases against Google and Facebook. Meanwhile, long-running criminal probes in the generic drug and poultry industries are heating up. Here’s a look at the biggest antitrust conduct cases to watch.
June 18, 2020
Even though a former top pharmaceutical executive at Taro Pharmaceutical Industries Ltd. is accused of lying to an FBI agent in New York about his participation in a price-fixing scheme, prosecutors say they want him to be tried in Pennsylvania.
May 20, 2020
A former top pharmaceutical executive facing price-fixing charges from the U.S. Department of Justice has requested that the case be moved from Pennsylvania to New York federal court.
February 04, 2020
The U.S. Department of Justice accused a former top executive at Taro Pharmaceutical Industries Ltd. of plotting to fix prices of antibiotics and diabetes treatments in Pennsylvania federal court on Tuesday — the third executive charged in the watchdog's criminal probe of the generic drug industry.